Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred over Other Modalities among People Who Inject Drugs: Findings from a Qualitative Study in California

Bazzi, A. R., Valasek, C. J., Streuli, S. A., Vera, C. F., Harvey-Vera, A., Philbin, M. M., Biello, K. B., Roth, A. M., Strathdee, S. A., & Pines, H. A. (2022). Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California. AIDS Patient Care and STDs, 36(7), 254–262. https://doi.org/10.1089/apc.2022.0068

Authors:

Angela R. Bazzi

Chad J. Valasek

Samantha A. Streuli

Carlos F. Vera

Alicia Harvey-Vera

Morgan M. Philbin

Katie B. Biello

Alexis M. Roth

Steffanie A. Strathdee

Heather A. Pines

Affiliated Authors: